The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Immune mediated conditions in autism spectrum disorders
Open accessAbstract
We conducted a case-control study among members of Kaiser Permanente Northern California (KPNC) born between 1980 and 2003 to determine the prevalence of immune-mediated conditions in individuals with autism, investigate whether these conditions occur more often than expected, and explore the timing of onset relative to autism diagnosis. Cases were children and young adults with at least two autism diagnoses recorded in outpatient records (n=5,565). Controls were children without autism randomly sampled at a ratio of 5 to 1, matched to cases on birth year, sex, and length of KPNC membership (n=27,825). The main outcomes - asthma, allergies, and autoimmune diseases - were identified from KPNC inpatient and outpatient databases. Chi-square tests were used to evaluate case-control differences. Allergies and autoimmune diseases were diagnosed significantly more often among children with autism than among controls (allergy: 20.6% vs. 17.7%, Crude odds ratio (OR) = 1.22, 95% confidence interval (CI) 1.13 – 1.31; autoimmune disease: 1% vs. 0.76%, OR = 1.36, 95% CI 1.01 – 1.83), and asthma was diagnosed significantly less often (13.7% vs. 15.9%; OR = 0.83, 95% CI 0.76 – 0.90). Psoriasis occurred more than twice as often in cases than in controls (0.34% vs. 0.15%; OR =2.35, 95% CI 1.36 – 4.08). Our results support previous observations that children with autism have elevated prevalence of specific immune-related comorbidities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lord, C., Risi, S., Lambrecht, L., Cook, E. H., Leventhal, B. L., DiLavore, P. C., Pickles, A., & Rutter, M. (2000) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1005592401947 · Cited by 7,520 · cited 2×
“However, a subset of 50 cases had been previously evaluated with the Autism Diagnostic Interview-Revised (ADI-R) (Lord et al., 1994) and the Autism Diagnostic Observation Schedule-Generic (ADOS-G) (Lord et al., 2000), and 94% met criteria for ASD on both instruments.”
Neuroglial activation and neuroinflammation in the brain of patients with autism
Vargas, D. L., Nascimbene, C., Krishnan, C., Zimmerman, A. W., & Pardo, C. A. (2005) · Annals of Neurology · doi:10.1002/ana.20315 · Cited by 2,149 · cited 2×
“…of biological markers of immune function in individuals with ASD have found neuroinflammation in brain tissues (Li et al., 2009; Pardo et al., 2005; Vargas et al., 2005), immunoglobulin imbalances, including increased levels of plasma IgG4 (Enstrom et al., 2009), reduced levels of IgG and IgM…”
Ashwood, P., Krakowiak, P., Hertz-Picciotto, I., Hansen, R., Pessah, I., & Van de Water, J. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.08.003 · Cited by 940 · cited 1×
“…2009), reduced levels of IgG and IgM (Heuer et al., 2008, 2012) or of total IgG (Grether et al., 2010); imbalances in cytokine/chemokine levels (Ashwood et al., 2011a–c; Suzuki et al., 2011), abnormal ratios of CD4+ to CD8+ T-cells or increased blood levels of nitric oxide metabolites (Stigler…”
The Co-Morbidity Burden of Children and Young Adults with Autism Spectrum Disorders
Kohane, I. S., McMurry, A., Weber, G., MacFadden, D., Rappaport, L., Kunkel, L., Bickel, J., Wattanasin, N., Spence, S., Murphy, S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033224 · Cited by 562
Gastrointestinal Problems in Children with Autism, Developmental Delays or Typical Development
Chaidez, V., Hansen, R. L., & Hertz-Picciotto, I. (2014) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-013-1973-x · Cited by 528
Gurney, J. G., McPheeters, M. L., & Davis, M. M. (2006) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.160.8.825 · Cited by 411
Cytokine dysregulation in autism spectrum disorders (ASD): Possible role of the environment
Goines, P. E., & Ashwood, P. (2013) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2012.07.006 · Cited by 314 · cited 1×
“A growing body of literature suggests that the immune system might be dysregulated in individuals affected by autism spectrum disorder (ASD) or their unaffected family members (Goines and Ashwood, 2013; Stigler et al., 2009).”
Altered T cell responses in children with autism
Ashwood, P., Krakowiak, P., Hertz-Picciotto, I., Hansen, R., Pessah, I. N., & Van de Water, J. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.09.002 · Cited by 281 · cited 1×
“…2009), reduced levels of IgG and IgM (Heuer et al., 2008, 2012) or of total IgG (Grether et al., 2010); imbalances in cytokine/chemokine levels (Ashwood et al., 2011a–c; Suzuki et al., 2011), abnormal ratios of CD4+ to CD8+ T-cells or increased blood levels of nitric oxide metabolites (Stigler…”
Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders
Ashwood, P., Krakowiak, P., Hertz-Picciotto, I., Hansen, R., Pessah, I. N., & Van de Water, J. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.10.025 · Cited by 279 · cited 1×
“…2009), reduced levels of IgG and IgM (Heuer et al., 2008, 2012) or of total IgG (Grether et al., 2010); imbalances in cytokine/chemokine levels (Ashwood et al., 2011a–c; Suzuki et al., 2011), abnormal ratios of CD4+ to CD8+ T-cells or increased blood levels of nitric oxide metabolites (Stigler…”
Enstrom, A. M., Lit, L., Onore, C. E., Gregg, J. P., Hansen, R. L., Pessah, I. N., Hertz-Picciotto, I., Van de Water, J. A., Sharp, F. R., & Ashwood, P. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.08.001 · Cited by 257 · cited 3×
“Studies of biological markers of immune function in individuals with ASD have found neuroinflammation in brain tissues (Li et al., 2009; Pardo et al., 2005; Vargas et al., 2005), immunoglobulin imbalances, including increased levels of plasma IgG4 (Enstrom et al., 2009), reduced levels of IgG and IgM (Heuer et al., 20…”
Reduced levels of immunoglobulin in children with autism correlates with behavioral symptoms
Heuer, L., Ashwood, P., Schauer, J., Goines, P., Krakowiak, P., Hertz‐Picciotto, I., Hansen, R., Croen, L. A., Pessah, I. N., & Van de Water, J. (2008) · Autism Research · doi:10.1002/aur.42 · Cited by 190
Self-citationMostafa, G. A., & Al-Ayadhi, L. Y. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.04.003 · Cited by 67
Heuer, L. S., Rose, M., Ashwood, P., & Van de Water, J. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.07.001 · Cited by 28
Cited by
An Overview of Autism Spectrum Disorder, Heterogeneity and Treatment Options
Masi, A., DeMayo, M. M., Glozier, N., & Guastella, A. J. (2017) · Neuroscience Bulletin · doi:10.1007/s12264-017-0100-y · Cited by 987
Blood–brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders
Fiorentino, M., Sapone, A., Senger, S., Camhi, S. S., Kadzielski, S. M., Buie, T. M., Kelly, D. L., Cascella, N., & Fasano, A. (2016) · Molecular Autism · doi:10.1186/s13229-016-0110-z · Cited by 494
The Immune System, Cytokines, and Biomarkers in Autism Spectrum Disorder
Masi, A., Glozier, N., Dale, R., & Guastella, A. J. (2017) · Neuroscience Bulletin · doi:10.1007/s12264-017-0103-8 · Cited by 260
Muskens, J. B., Velders, F. P., & Staal, W. G. (2017) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-017-1020-0 · Cited by 232
“…et al. 2014 54/46 3–9 Cross-sectional Antibody levels of HSV 1 and HSV 2 Puig–Alcatraz et al. 2015 35/34 4–13 Cross-sectional Homocysteine levels Zerbo et al. 2015 5565/27,825 3–26 Case–control Immune-mediated conditions Gastroenterology Valicenti et al. 2006 50/100 4–12 Cross-sectional…”
Tye, C., Runicles, A. K., Whitehouse, A. J. O., & Alvares, G. A. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00751 · Cited by 177
Metadata
- Authors
- Zerbo, O., Leong, A., Barcellos, L., Bernal, P., Fireman, B., & Croen, L. A.
- Venue
- Brain, Behavior, and Immunity
- Publisher
- Elsevier BV
- Published
- 2015-05
- Volume
- 46
- Pages
- 232-236
- ISSN
- 0889-1591 (ISSN-L)
- OpenAlex
- W2048394248
- Cited by
- 163
- References
- 13
- FWCI
- 8.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.